• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人补体对水疱性口炎病毒(VSV)的中和作用需要人血清中存在的天然IgM抗体。

Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.

作者信息

Beebe D P, Cooper N R

出版信息

J Immunol. 1981 Apr;126(4):1562-8.

PMID:6259260
Abstract

Neutralization of VSV by human serum ws previously shown to involve C1, C2, C3, and C4 of the classical complement (C) pathway. All normal human sera tested were equivalently active in this regard. However, purified C1, C2, C3, and C4 were unable to mediate VSV neutralization. In the present studies an additional factor required for C-mediated neutralization was isolated from normal human serum and identified as a natural IgM antibody specific for a viral encoded antigen. Purified IgM bound to the virus and formed a complex that activated component C1. Normal serum concentrations of purified IgM, C1, C2, C3, C4 neutralized VSV to the same extent as normal serum. Purified IgM did not neutralize VSV alone or in conjunction with C1, C2, and C4. Inclusion of C3 resulted in full neutralization and C3b binding to the virus was demonstrated. Thus, normal human serum contains a natural antibody of the IgM class that is directed toward a viral antigen. The antibody facilitates neutralization by forming an immune complex that activates C1 and thus efficiently initiates the classical pathway at the viral surface. Neutralization occurs with C3b deposition on the viral envelope and probably results from a blanket of C protein that interferes with viral attachment to susceptible cells.

摘要

先前已证明人血清对水疱性口炎病毒(VSV)的中和作用涉及经典补体(C)途径的C1、C2、C3和C4。所有测试的正常人血清在这方面的活性相当。然而,纯化的C1、C2、C3和C4无法介导VSV的中和作用。在本研究中,从正常人血清中分离出C介导的中和作用所需的另一种因子,并鉴定为一种针对病毒编码抗原的天然IgM抗体。纯化的IgM与病毒结合并形成激活C1成分的复合物。纯化的IgM、C1、C2、C3、C4在正常血清浓度下对VSV的中和程度与正常血清相同。纯化的IgM单独或与C1、C2和C4联合使用时均不能中和VSV。加入C3可导致完全中和,并证明C3b与病毒结合。因此,正常人血清中含有一种针对病毒抗原的IgM类天然抗体。该抗体通过形成激活C1的免疫复合物促进中和作用,从而在病毒表面有效地启动经典途径。中和作用伴随着C3b沉积在病毒包膜上,可能是由于一层C蛋白干扰了病毒与易感细胞的附着。

相似文献

1
Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.人补体对水疱性口炎病毒(VSV)的中和作用需要人血清中存在的天然IgM抗体。
J Immunol. 1981 Apr;126(4):1562-8.
2
Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.人补体对水疱性口炎病毒的非抗体依赖性中和作用。II. 人血清中VSV-脂蛋白复合物的形成及补体依赖性病毒裂解
J Immunol. 1979 Dec;123(6):2518-24.
3
Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.选择性补体缺乏对人血清中和包膜病毒速率的影响。
J Immunol. 1977 Jan;118(1):28-34.
4
Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.正常人血清对流感病毒的中和作用:涉及抗体和补体的机制。
J Immunol. 1983 Mar;130(3):1317-22.
5
Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.经典途径激活的表面调节:绵羊、豚鼠和人红细胞上C2和C3转化酶的形成与调节
J Immunol. 1983 Jul;131(1):403-8.
6
Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.新生C3b和C4b对C1激活的控制:一种反馈抑制机制。
J Immunol. 1986 May 1;136(9):3378-83.
7
Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements.人补体对水疱性口炎病毒的非抗体依赖性中和作用。I. 补体需求
J Immunol. 1978 Oct;121(4):1549-57.
8
Prevention of immune precipitation by purified classical pathway complement components.利用纯化的经典途径补体成分预防免疫沉淀。
Clin Exp Immunol. 1984 Nov;58(2):486-92.
9
Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.经典补体激活途径第一步的可能机制:C1的结合与激活。
Immunology. 1978 Dec;35(6):873-84.
10
Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.松萝酸对人血清补体的影响包括干扰C1抑制剂功能。
J Immunol. 1982 Jul;129(1):168-72.

引用本文的文献

1
Newly discovered and conserved role of IgM against viral infection in an early vertebrate.IgM在早期脊椎动物中对抗病毒感染的新发现及保守作用。
Elife. 2025 Sep 4;14:RP104465. doi: 10.7554/eLife.104465.
2
Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals.补体介导的接种个体中SARS-CoV-2抗体中和效力增强
Nat Commun. 2025 Mar 18;16(1):2666. doi: 10.1038/s41467-025-57947-8.
3
Direct enhancement of viral neutralising antibody potency by the complement system: a largely forgotten phenomenon.
补体系统直接增强病毒中和抗体效力:一个被广泛遗忘的现象。
Cell Mol Life Sci. 2024 Jan 11;81(1):22. doi: 10.1007/s00018-023-05074-2.
4
Severe COVID-19: Drugs and Clinical Trials.重症新型冠状病毒肺炎:药物与临床试验
J Clin Med. 2023 Apr 16;12(8):2893. doi: 10.3390/jcm12082893.
5
Emerging systemic delivery strategies of oncolytic viruses: A key step toward cancer immunotherapy.溶瘤病毒新兴的全身给药策略:癌症免疫治疗的关键一步。
Nano Res. 2022;15(5):4137-4153. doi: 10.1007/s12274-021-4031-6. Epub 2022 Feb 14.
6
Functional Dissection of the Dominant Role of CD55 in Protecting Vesicular Stomatitis Virus against Complement-Mediated Neutralization.解析 CD55 在保护水疱性口炎病毒免受补体介导的中和作用中的主要作用。
Viruses. 2021 Feb 26;13(3):373. doi: 10.3390/v13030373.
7
Immunoglobulin M in Health and Diseases: How Far Have We Come and What Next?免疫球蛋白 M 在健康与疾病中的作用:我们已经走了多远,下一步该如何?
Front Immunol. 2020 Oct 30;11:595535. doi: 10.3389/fimmu.2020.595535. eCollection 2020.
8
In the Crosshairs: RNA Viruses OR Complement?在瞄准镜中:RNA 病毒还是补体?
Front Immunol. 2020 Sep 29;11:573583. doi: 10.3389/fimmu.2020.573583. eCollection 2020.
9
The stability of envelope-pseudotyped lentiviral vectors.包膜假型慢病毒载体的稳定性。
Gene Ther. 2021 Feb;28(1-2):89-104. doi: 10.1038/s41434-020-00193-y. Epub 2020 Sep 24.
10
Interactions of viruses and the humoral innate immune response.病毒与体液固有免疫反应的相互作用。
Clin Immunol. 2020 Mar;212:108351. doi: 10.1016/j.clim.2020.108351. Epub 2020 Feb 4.